Joseph J. Larosa, EVP General Counsel and Secret at REGENERON PHARMACEUTICALS, INC. (REGN), sold 7,164 shares at $515.70 ($3.7M) on 2020-04-15, disclosed to the SEC on 2020-04-16.
Open-market sale of $3.7M REGN by EVP General Counsel and Secret. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $521.45 | 2,738 | $1.4M | 38.4% |
| 2 | $514.63 | 92 | $47K | 1.3% |
| 3 | $515.70 | 414 | $214K | 5.7% |
| 4 | $515.70 | 414 | $213K | 5.7% |
| 5 | $516.81 | 260 | $134K | 3.6% |
| 6 | $516.81 | 260 |
| $134K |
| 3.6% |
| 7 | $517.40 | 266 | $138K | 3.7% |
| 8 | $517.40 | 266 | $138K | 3.7% |
| 9 | $518.25 | 499 | $259K | 6.9% |
| 10 | $518.25 | 499 | $259K | 6.9% |
| 11 | $519.43 | 286 | $149K | 4.0% |
| 12 | $519.43 | 286 | $149K | 4.0% |
| 13 | $520.45 | 220 | $114K | 3.1% |
| 14 | $520.45 | 220 | $114K | 3.1% |
| 15 | $521.05 | 113 | $59K | 1.6% |
| 16 | $521.05 | 113 | $59K | 1.6% |
| 17 | $524.99 | 106 | $56K | 1.5% |
| 18 | $524.99 | 106 | $56K | 1.5% |
| 19 | $525.30 | 6 | $3K | 0.1% |
| Total | $519.49 avg | 7,164 | $3.7M | 100% |
| Filing → |
| REGN | SELL | 2024-02-28 | $990K | — | Filing → |
| REGN | SELL | 2024-02-26 | $968K | — | Filing → |
| REGN | SELL | 2024-02-09 | $950K | — | Filing → |